These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18687903)

  • 1. PINK1 in mitochondrial function.
    Plun-Favreau H; Hardy J
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11041-2. PubMed ID: 18687903
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.
    Gautier CA; Kitada T; Shen J
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11364-9. PubMed ID: 18687901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
    Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism.
    Inoue N; Ogura S; Kasai A; Nakazawa T; Ikeda K; Higashi S; Isotani A; Baba K; Mochizuki H; Fujimura H; Ago Y; Hayata-Takano A; Seiriki K; Shintani Y; Shintani N; Hashimoto H
    EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29371327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.
    Villeneuve LM; Purnell PR; Boska MD; Fox HS
    Mol Neurobiol; 2016 Jan; 53(1):171-186. PubMed ID: 25421206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling.
    Rüb C; Schröder N; Voos W
    Biochem Soc Trans; 2015 Apr; 43(2):287-91. PubMed ID: 25849931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.
    Grünewald A; Gegg ME; Taanman JW; King RH; Kock N; Klein C; Schapira AH
    Exp Neurol; 2009 Sep; 219(1):266-73. PubMed ID: 19500570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease.
    Pilsl A; Winklhofer KF
    Acta Neuropathol; 2012 Feb; 123(2):173-88. PubMed ID: 22057787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: pro-survival effects of PINK1.
    Abeliovich A
    Nature; 2007 Aug; 448(7155):759-60. PubMed ID: 17700685
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial dysfunction in Parkinson's disease.
    Schapira AH
    Cell Death Differ; 2007 Jul; 14(7):1261-6. PubMed ID: 17464321
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitochondria in human diseases and animal evolution.
    Liu SJ; Zhang YP
    Curr Mol Med; 2014; 14(10):1245-6. PubMed ID: 25470294
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
    Barodia SK; Creed RB; Goldberg MS
    Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contacts.
    Parrado-Fernández C; Schneider B; Ankarcrona M; Conti MM; Cookson MR; Kivipelto M; Cedazo-Mínguez Á; Sandebring-Matton A
    J Cell Mol Med; 2018 Nov; 22(11):5439-5449. PubMed ID: 30133157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mitochondrial disfunction in Parkinson's disease].
    Buneeva OA; Medvedev AE
    Biomed Khim; 2011; 57(3):246-81. PubMed ID: 21863741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: Mitochondrial damage control.
    Abeliovich A
    Nature; 2010 Feb; 463(7282):744-5. PubMed ID: 20148026
    [No Abstract]   [Full Text] [Related]  

  • 17. PINK1 targets dysfunctional mitochondria for autophagy in Parkinson disease.
    Jones N
    Nat Rev Neurol; 2010 Apr; 6(4):181. PubMed ID: 20383881
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease.
    Abahuni N; Gispert S; Bauer P; Riess O; Krüger R; Becker T; Auburger G
    Neurosci Lett; 2007 Mar; 414(2):126-9. PubMed ID: 17267121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes.
    O'Flanagan CH; Morais VA; Wurst W; De Strooper B; O'Neill C
    Oncogene; 2015 Mar; 34(11):1363-74. PubMed ID: 24681957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the mitochondrial NCX in the mechanism of neurodegeneration in Parkinson's disease.
    Wood-Kaczmar A; Deas E; Wood NW; Abramov AY
    Adv Exp Med Biol; 2013; 961():241-9. PubMed ID: 23224884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.